Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Medicinal Chemistry|June 23, 2007
Dual action-based approaches to antibacterial agentsJohn B Bremner, Joseph I Ambrus, Siritron SamosornBioorganic & Medicinal Chemistry Letters|July 18, 2008
Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureusJoseph I Ambrus, Michael J Kelso, John B Bremner, et al.Bioorganic & Medicinal Chemistry Letters|December 15, 2016
Identification and validation of small molecule modulators of the NusB-NusE interactionPeter J Cossar, Cong Ma, Christopher P Gordon, et al.Chemical Communications (Cambridge, England)|May 26, 2012
Covalent attachment of antagonists to the α7 nicotinic acetylcholine receptor: synthesis and reactivity of substituted maleimidesJoseph I Ambrus, Jill I Halliday, Nicholas Kanizaj, et al.Bioanalysis|March 29, 2013
The metabolism of anabolic-androgenic steroids in the greyhoundAndrew R McKinney, Adam T Cawley, E Bruce Young, et al.The Journal of Biological Chemistry|July 30, 2013
Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealedNathan L Absalom, Gracia Quek, Trevor M Lewis, et al.ACS Chemical Neuroscience|July 11, 2012
Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptorsGracia X J Quek, Diana Lin, Jill I Halliday, et al.RSC Medicinal Chemistry|August 18, 2023
The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal modelsLuke R Odell, Nigel C Jones, Ngoc Chau, et al.ACS Chemical Biology|June 18, 2026
Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal ModelsNigel C Jones, Mark J Robertson, Luke R Odell, et al.Pageof 1